CAPE TOWN - South Africa's first Covid-19 jab has been designed, developed and manufactured.
It's now waiting to go on trial.
Health authorities have hosted a European Commission delegation on a tour of the Afrigen Biologics and Vaccines facility in Cape Town.
Europe has committed to keep supporting local manufacturing capabilities, and to strengthen pharmaceutical systems.
eNCA's Ayesha Ismail spoke to Afrigen managing director, Petro Terblanche.